Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

Published Date: 27 Dec 2023

A method for predicting which patients will benefit from radium-223, a common treatment for advanced prostate cancer that has spread to the bones, has been developed by researchers.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

2.

Veterans of the Navy have high lung cancer rates associated with asbestos use.

3.

In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.

4.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

5.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot